Sitagliptin - Pharmaceutical Impurities | SZEB

Sitagliptin was developed by Merck & Co. and approved for medical use in the United States in 2006.Sitagliptin is an anti-diabetic medication used to treat type 2 diabetes.

We manufacture and furnish high quality Sitagliptin impurity for global markets. More information is available on the official website: https://www.ex-biotech.com. If you have any questions, please send an email to sale@ex-biotech.com. We are looking forward to cooperating with you.

The following are some of the impurities of Sitagliptin :